Glaucoma

Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.

LL-BMT1 is a sustained drug delivery approach via a 3D-printed, drug-eluting contact lens to be used in glaucoma care that successfully completed a Phase 2b clinical trial.

At the Envision Summit 2025 in San Juan, Puerto Rico, Jessica Steen, OD, FAAO talked with glaucoma surgeons on the importance of comanaging patients throughout their lifetime.

At Glaucoma 360 2025, Danica Marrelli, OD, FAAO, dove into the data on visual field testing for patients with glaucoma.

Attention to patients' near visual needs is warranted when choosing medications.

The CREST Registry study reported on the safety and effectiveness outcomes of microinvasive cyclodialysis clef formation with the CycloPen system, followed by scleral reinforcement with AlloFlo Bio-Tissue implantation, according to Iantrek.

All QLS-111 concentrations and dose regimens in both Osprey and Apteryx trials “demonstrated excellent safety and tolerability,” according to the company.

C.Rex is the only MGIS technology on the market that allows for fully titratable 180-360 comprehensive intervention.

The 12-year nationwide cohort found that significant differences in open angle glaucoma risk when assessing the presence of aura were not recorded between the study groups.

Preservatives may disrupt the ocular surface, contributing to poor adherence.

Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.

The guideline, titled "Care of the Patient with Primary Open-Angle Glaucoma," was developed by the AOA Evidence-based Optometry Guideline Development Group.

Whitecap is currently developing 2 therapies for potential use in glaucoma and geographic atrophy.

Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.

Educational material available include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, and a dedicated webpage.

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management.

Tenpoint Therapeutics and Visus Therapeutics have merged to focus on aging-related ocular conditions, with key products including BRIMOCHOL PF for presbyopia and therapies for cataracts and geographic atrophy.

The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.

The company begins phase 1 trials of oral GAL-101, targeting amyloid beta aggregation for potential treatment of dry AMD, glaucoma, and neurodegenerative eye diseases.

The primary findings were that a higher BMI was protective against glaucoma progression and use of tobacco and alcohol were not significantly associated with retinal nerve fiber layer change.

A retrospective cohort study was designed to provide further information on the association between BP parameters and VF progression over time.

Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.

Puzzle-piecing a new patient’s medical history together takes many forms.

The weekly drug-eluting contact lens was created by the company’s proprietary 3D printing technology and met all primary end points with no serious adverse events reported in either cohort.

At AAOpt, Dr. Justin Schweitzer talks about myths surrounding ocular surgery and comanagement of surgical patients.

Dr. Justin Schweitzer's 2024 AAOpt talk will cover the latest advancements in ocular drug delivery, including topical, implant, and contact lens-based methods that can improve patient quality of life, adherence, and financial burden.

Julie Rodman, OD, MS, FAAO, details a Rapid Fire session she presented at this year's American Academy of Optometry meeting, which features a case study on retinal vein occlusion.

The study estimated that found approximately 4.22 million people in the US have glaucoma, with as many as 1.49 million people with vision-affecting glaucoma.

As much as 96% of customers and 60% of patients can get their results in less than a minute with Retinalyze, according to the company.

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive management techniques, aiming to enhance patient outcomes in glaucoma care.